Dashboard
Manage Tickers

INSMINSMED Inc

Nasdaq insmed.com


$ 57.81 $ 0.83 (1.46 %)    

Wednesday, 05-Jun-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 9.16 (2.02 %)
DIA $ 398.57 $ 1.02 (0.26 %)
SPY $ 530.36 $ 6.28 (1.19 %)
TLT $ 91.26 $ 0.68 (0.73 %)
GLD $ 225.37 $ 2.55 (1.18 %)
$ 57.83
$ 58.00
$ 0.00 x 0
$ 0.00 x 0
$ 55.81 - $ 58.22
$ 18.77 - $ 58.82
2,578,938
na
8.59B
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 10-26-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 04-30-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 10-30-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 10-30-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-02-2017 09-30-2017 10-Q
28 08-03-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-25-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-06-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

stifel-maintains-buy-on-insmed-raises-price-target-to-74
Stifel Maintains Buy on Insmed, Raises Pri...
06/05/2024 13:22:10

Stifel analyst Stephen Willey maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $67 to $74.

stifel-maintains-buy-on-insmed-raises-price-target-to-67
Stifel Maintains Buy on Insmed, Raises Pri...
05/31/2024 13:23:29

Stifel analyst Stephen Willey maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $39 to $67.

Core News & Articles
HP Posts Upbeat Earnings, Joins Foot Locke...
05/30/2024 14:45:25

insmed-announces-pricing-of-650m-public-offering-of-12621359-shares-at-5150share
Insmed Announces Pricing Of $650M Public O...
05/30/2024 12:06:00

td-cowen-maintains-buy-on-insmed-raises-price-target-to-67
TD Cowen Maintains Buy on Insmed, Raises P...
05/29/2024 14:57:21

TD Cowen analyst Ritu Baral maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $45 to $67.

ubs-maintains-buy-on-insmed-raises-price-target-to-58
UBS Maintains Buy on Insmed, Raises Price ...
05/29/2024 13:58:42

UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $46 to $58.

goldman-sachs-maintains-buy-on-insmed-raises-price-target-to-74
Goldman Sachs Maintains Buy on Insmed, Rai...
05/29/2024 13:53:42

Goldman Sachs analyst Andrea Tan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $49 to $74.

wells-fargo-maintains-overweight-on-insmed-raises-price-target-to-77
Wells Fargo Maintains Overweight on Insmed...
05/29/2024 13:23:10

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $55 to $77.

truist-securities-maintains-buy-on-insmed-raises-price-target-to-68
Truist Securities Maintains Buy on Insmed,...
05/29/2024 12:54:36

Truist Securities analyst Nicole Germino maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $48 to $68.

barclays-maintains-overweight-on-insmed-raises-price-target-to-63
Barclays Maintains Overweight on Insmed, R...
05/29/2024 12:29:23

Barclays analyst Leon Wang maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $40 to $63.

jp-morgan-maintains-overweight-on-insmed-raises-price-target-to-55
JP Morgan Maintains Overweight on Insmed, ...
05/29/2024 12:09:46

JP Morgan analyst Jessica Fye maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $36 to $55.

b-of-a-securities-maintains-buy-on-insmed-raises-price-target-to-62
B of A Securities Maintains Buy on Insmed,...
05/29/2024 12:05:26

B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $40 to $62.

hc-wainwright--co-maintains-buy-on-insmed-raises-price-target-to-70
HC Wainwright & Co. Maintains Buy on Insme...
05/29/2024 10:24:55

HC Wainwright & Co. analyst Andrew Fein maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $52 t...

reported-earlier-insmed-to-raise-500m-through-public-offering-of-common-stock
Reported Earlier, Insmed To Raise $500M Th...
05/29/2024 07:06:12

crude-oil-rises-sharply-elbit-systems-shares-fall-after-q1-results
Crude Oil Rises Sharply; Elbit Systems Sha...
05/28/2024 18:34:02

why-applied-dna-sciences-shares-are-trading-lower-by-around-68-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Applied DNA Sciences Shares Are Tradin...
05/28/2024 17:24:16

b-of-a-securities-maintains-buy-on-insmed-maintains-40-price-target
B of A Securities Maintains Buy on Insmed,...
05/28/2024 17:05:55

B of A Securities analyst Jason Zemansky maintains Insmed (NASDAQ:INSM) with a Buy and maintains $40 price target.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/28/2024 16:31:12

dow-dips-over-100-points-gamestop-shares-spike-higher
Dow Dips Over 100 Points; GameStop Shares ...
05/28/2024 16:00:17

nvidia-insmed-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Nvidia, Insmed, Agios Pharmaceuticals And ...
05/28/2024 14:31:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION